General Info
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Location: Suzhou
Country:
Industries:
Investment Regions: EU, NA, SEA
Investment Stages: late-stage, pre-seed, seed, series-a
Website: http://www.innoventbio.com/
EU, NA, SEA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Search results show major partnership and deal announcements in Oct 2025 (e.g., Takeda partnership announced Oct 22, 2025) and interim results Aug 27, 2025 indicating recent active business transactions. The most recent known investment/partnering activity is within 3 months, classifying as very-active. The invested/partnered company mentioned: Takeda (collaboration regarding Innovent’s oncology assets).
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Innovent Biologics
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI